Clinical trial
A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy…
NCT00367432 · UCB Japan Co. Ltd., Industry · Completed
Key facts
| NCT number | NCT00367432 |
|---|---|
| Title | A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures |
| Official title | A Multicenter, Open, Long-term Follow-up Study to Evaluate the Safety and Efficacy of L059 (Levetiracetam) at Individual Optimal Dose Ranging From 500 to 3000 mg/Day in Twice Daily Administration in Subjects From 16 to 65 Years With Epilepsy Suffering From Partial Onset Seizures Whether or Not… |
| Lead sponsor | UCB Japan Co. Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsies, Partial |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 398 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Aug 22, 2006 |
| Last update posted | Nov 13, 2020 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: